Related Experiment Video
Updated: May 6, 2026
05:23
Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
895
Population based Helicobacter pylori screening and eradication: advances versus side effects
1AM DC Rogaska, Prvomajska 29A, Rogaska Slatina, Slovenia. bojan.tepes@siol.net.
Current Pharmaceutical Design
|November 5, 2013
Summary
Early eradication of Helicobacter pylori (H pylori) infection can prevent gastric cancer development. National screening and H pylori eradication are recommended in high-incidence regions to reduce cancer deaths.
Area of Science:
- Gastroenterology
- Oncology
- Infectious Disease
Background:
- Gastric cancer is a leading cause of cancer death globally, with incidence projected to rise.
- Helicobacter pylori (H pylori) infection is a major risk factor, implicated in 60-80% of gastric cancers.
- Premalignant gastric lesions and cancer can be prevented by early H pylori eradication.
Purpose of the Study:
- To highlight the significance of H pylori in gastric carcinogenesis.
- To advocate for national screening and eradication strategies for H pylori.
- To outline recommended diagnostic and surveillance approaches for gastric cancer prevention.
Main Methods:
- Review of animal and intervention studies on H pylori eradication.
- Discussion of eradication therapy protocols and success monitoring.
- Emphasis on endoscopic and histologic surveillance for preneoplastic lesions using staging systems (OLGA/OLGIM, A-D).
Main Results:
- Early H pylori eradication significantly reduces the risk of premalignant gastric lesions and gastric cancer.
- Quadruple bismuth or non-bismuth therapies achieve >90% H pylori eradication rates when guided by local resistance data.
- Noninvasive serological tests (pepsinogen I, PGI/PGII ratio, H pylori antibodies) can identify high-risk individuals in endemic areas.
Conclusions:
- National screening for H pylori infection and subsequent eradication are crucial in high-incidence countries.
- Risk stratification using staging systems and serological markers aids in targeted endoscopic surveillance.
- Timely intervention against H pylori is a key strategy for gastric cancer prevention.
Related Concept Videos
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
2.5K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.5K
01:27Peptic Ulcer
53
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
53
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
1.0K
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
1.0K
01:26Peptic Ulcer Disease IV: Management
821
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
821
01:25Peptic Ulcer Disease III: Clinical Manifestations and Complications
71
Duodenal UlcersDuodenal ulcers are the most common form of peptic ulcer disease, presenting with chronic, intermittent epigastric pain. Pain typically appears 2–3 hours after meals, especially when the stomach is empty, often waking patients at night. It is characteristically relieved by food or antacids (“pain–food–relief”). Some patients remain asymptomatic until complications like bleeding or perforation emerge, particularly with NSAID or anticoagulant...
71
01:26Gastritis II: Pathophysiology
89
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
89